Full Text
PND10 SWITCHING TO HIGH-DOSE HIGH-FREQUENCY INTERFERONS OR NATALIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS- A COST-EFFECTIVENESS ANALYSIS

Abstract

Authors

C Fincher D Meletiche LD Goldberg

Back to Volume 11, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×